Andrew P. Smith
2015
In 2015, Andrew P. Smith earned a total compensation of $1.4M as Former Chief Financial Officer at Sucampo Pharmaceuticals, a 147% increase compared to previous year.
Compensation breakdown
| Bonus | $53,600 |
|---|---|
| Non-Equity Incentive Plan | $210,477 |
| Option Awards | $685,038 |
| Salary | $349,768 |
| Other | $110,861 |
| Total | $1,409,744 |
Smith received $685K in option awards, accounting for 49% of the total pay in 2015.
Smith also received $53.6K in bonus, $210.5K in non-equity incentive plan, $349.8K in salary and $110.9K in other compensation.
Rankings
In 2015, Andrew P. Smith's compensation ranked 6,294th out of 13,638 executives tracked by ExecPay. In other words, Smith earned more than 53.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,294 out of 13,638 | 54th |
Division Manufacturing | 2,363 out of 5,190 | 55th |
Major group Chemicals And Allied Products | 851 out of 1,854 | 54th |
Industry group Drugs | 681 out of 1,528 | 55th |
Industry Pharmaceutical Preparations | 530 out of 1,182 | 55th |
Source: SEC filing on April 21, 2017.
Smith's colleagues
We found six more compensation records of executives who worked with Andrew P. Smith at Sucampo Pharmaceuticals in 2015.
2015
Peter Greenleaf
Sucampo Pharmaceuticals
Chief Executive Officer
2015
Peter Kiener
Sucampo Pharmaceuticals
Chief Scientific Officer
2015
Thomas Knapp
Sucampo Pharmaceuticals
Chief Legal Officer
2015
Matthias Alder
Sucampo Pharmaceuticals
General Counsel
2015
Peter Lichtlen
Sucampo Pharmaceuticals
Chief Medical Officer
2015
Max Donley
Sucampo Pharmaceuticals